Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Exicure, Inc. (XCUR)

CollPlant Biotechnologies Ltd. Sponsored ADR and Exicure, Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and Exicure, Inc. are of similar size ($7.3M and $7.0M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against −86.8%. Exicure, Inc. has the higher net margin (0.00% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Exicure, Inc. leads on 12 and CollPlant Biotechnologies Ltd. Sponsored ADR on 4.

Valuation

Metric CLGN XCUR Biotechnology median
P/E n/m n/m 8.50
P/S 16.34 0.26 9.71
P/B 1.76 7.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 24.21 0.24 9.21
Earnings yield (263.11%) (118.92%) (33.15%)
Free cash flow yield (216.45%) (84.13%) (25.50%)

Profitability

Metric CLGN XCUR Biotechnology median
Gross margin (321.70%) 80.08% 65.16%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) (168.37%) (56.36%)
Return on assets (101.59%) (54.98%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLGN XCUR Biotechnology median
Revenue growth (TTM) (86.76%) 2,366.45% 6.02%
EPS growth (last fiscal year) 35.17% 83.37% 30.26%
Revenue growth, 5-year CAGR (17.32%) 33.48% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN XCUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 0.56 4.72
Net debt to EBITDA 0.56 0.99 0.96

Dividend

Metric CLGN XCUR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLGN XCUR Biotechnology median
Market cap 6.96m 7.33m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack